Published
1 month agoon
By
Adam BeechThe Respiratory Diseases Research Use Only (RUO) Panel is intended to support research to distinguish between types of chronic inflammatory airway disease, including asthma, chronic obstructive pulmonary disease (COPD), and idiopathic pulmonary fibrosis (IPF), as well as to facilitate better therapeutic decision making and monitoring.
The panel consists of a set of biologically relevant Volatile Organic Compounds (VOCs) that have been linked to inflammatory respiratory diseases and can be easily collected on breath to enable direct characterisation of disease biology in the lungs by non-invasively sampling the airways.
It will initially be introduced for research use only as part of an expanded breath biopsy products and services offering to supplement the breath biopsy OMNI assay.
Additionally, it will be used by pharmaceutical and academic/clinical research clients to support therapeutic development through characterisation of disease endotypes and monitoring response to therapy, as well as to better understand the onset, development and exacerbation of disease.
Billy Boyle, co-founder and CEO at Owlstone Medical, said: “The Respiratory Diseases RUO Panel is the first to be commercially launched by Owlstone Medical and opens an important new phase in the application of breath to address areas of high clinical need.
“Building on our recent announcement on the use of limonene as an EVOC probe in NASH/NAFLD, this panel further validates our strategy of identifying promising biomarkers from multiple sources, including endogenous discovery, EVOC probes, and in-licensing.
“We look forward to making further announcements as our robust test pipeline continues to develop.”
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.